About
Dr. Scott Robinson joined Vickers in 2021 and founded MicroQuin, a biotechnology company working on treatments for oncology, anti-infectives and neurodegenerative diseases. He has experience defining drug development roadmaps with the FDA and EMA and continues to work with NASA on experiments aboard the international space station, as well as collaborating with Harvard University, Imperial College London and the University of Bristol. He previously worked as a protein biochemist at GlaxoSmithKline and in quantitative risk management at investment banks including Morgan Stanley, Credit Suisse and Nomura.
Invests in
Biotech
Colleagues at Vickers Venture Partners
Bernice Teo
Executive Assistant at Vickers Venture Partners
Christine Ong
Accountant at Vickers Venture Partners
Damian Tan
Managing Director at Vickers Venture Partners
Dr Damian Tan
Managing Director at Vickers Venture Partners
Dr Finian Tan
Chairman, CIO at Vickers Venture Partners
Dr Jeffrey Chi
Senior Consultant at Vickers Venture Partners
Dr Khalil Binebine
Senior Consultant at Vickers Venture Partners
Dr Poh Hui Chia
Director at Vickers Venture Partners